SOURCE: Rothman Research

Rothman Research

November 23, 2009 06:58 ET

Rothman Research Finished Updated Research on The Allstate Corporation, Pitney Bowes Inc., Tenaris S.A., Nucor Corporation, Titanium Metals Corporation and ADVENTRX Pharmaceuticals Inc.

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by RothmanResearch.com.

NEW DELHI, INDIA--(Marketwire - November 23, 2009) - The sellers were able to dog stocks for the entire session and hand the S&P 500 its worst single-session percentage loss of the month as buyers stepped to the sidelines amid a lack of positive catalysts. All leading exchange slipped in U.S. As today's market news unfolds Rothman Research begun tracking the following companies The Allstate Corporation (NYSE: ALL), Pitney Bowes Inc. (NYSE: PBI), Tenaris S.A. (NYSE: TS), Nucor Corporation (NYSE: NUE), Titanium Metals Corporation (NYSE: TIE) and ADVENTRX Pharmaceuticals Inc. (NYSE: ANX) as they have shown remarkable correction in recent days.

Here are a few sneak-peeks of the actual analyst reports you will find in our members' area:

ALL is having resistance at $32 levels. It has given 13% return in the last 6 months.

PBI is having resistance at $26 levels.

TS's results in the third quarter reflect weak demand for its products and...

NUE has come down from the levels of $50. It is having strong support at $38 levels and...

TIE is trading at its resistance levels. It has given 23% return in the last 6 months.

ANX's third quarter results reflect its continued efforts to carefully manage and...

At Rothman Research we have the fastest accurate system for locating, analyzing, and reporting, which allows us to rapidly provide you with all the information you need to make a sound investment decision. On top of this we have a golden rule and we believe you will agree that knowledge is free and should accessible to everybody.

Take the time to register with us at www.rothmanresearch.com

RothmanResearch.com has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.